Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer-Associated Glycosphingolipids as Tumor Markers and Targets for Cancer Immunotherapy
Sophie Groux‐Degroote, Philippe Delannoy
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 6145-6145
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Targeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives
Nora Berois, Álvaro Pittini, Eduardo Osinaga
Cancers (2022) Vol. 14, Iss. 3, pp. 645-645
Open Access | Times Cited: 77
Glycan-specific molecularly imprinted polymers towards cancer diagnostics: merits, applications, and future perspectives
Pengfei Li, Zhen Liu
Chemical Society Reviews (2024) Vol. 53, Iss. 4, pp. 1870-1891
Closed Access | Times Cited: 37
Nanotechnology-based approaches for effective detection of tumor markers: A comprehensive state-of-the-art review
Ushna Laraib, Saman Sargazi, Abbas Rahdar, et al.
International Journal of Biological Macromolecules (2021) Vol. 195, pp. 356-383
Closed Access | Times Cited: 100
The Effect of Hypoxia and Hypoxia-Associated Pathways in the Regulation of Antitumor Response: Friends or Foes?
Raefa Abou Khouzam, Rania F. Zaarour, Klaudia Brodaczewska, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 49
Anti-GD2 Directed Immunotherapy for High-Risk and Metastatic Neuroblastoma
Gcf Chan, Carol Matias Chan
Biomolecules (2022) Vol. 12, Iss. 3, pp. 358-358
Open Access | Times Cited: 40
Association between abnormal lipid metabolism and tumor
Chunyu Li, Fei Wang, Lili Cui, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 23
State of the Art in CAR-T Cell Therapy for Solid Tumors: Is There a Sweeter Future?
Beatriz Amorós-Pérez, Benigno Rivas-Pardo, Manuel Gómez del Moral, et al.
Cells (2024) Vol. 13, Iss. 9, pp. 725-725
Open Access | Times Cited: 12
Effect of the Lipid Landscape on the Efficacy of Cell-Penetrating Peptides
Florina Zákány, István M. Mándity, Zoltán Varga, et al.
Cells (2023) Vol. 12, Iss. 13, pp. 1700-1700
Open Access | Times Cited: 18
It Takes More than Two to Tango: Complex, Hierarchal, and Membrane-Modulated Interactions in the Regulation of Receptor Tyrosine Kinases
Tamás Kovács, Florina Zákány, Péter Nagy
Cancers (2022) Vol. 14, Iss. 4, pp. 944-944
Open Access | Times Cited: 28
The altered lipidome of hepatocellular carcinoma
Shawn Lu Wen Tan, Erez Israeli, Russell Ericksen, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 445-456
Closed Access | Times Cited: 25
Current state-of-the-art on ganglioside-mediated immune modulation in the tumor microenvironment
Irene van der Haar Àvila, Britt Windhouwer, Sandra J. van Vliet
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 3, pp. 941-958
Open Access | Times Cited: 16
Cancer glycomics offers potential biomarkers and therapeutic targets in the framework of 3P medicine
Yuna Guo, Wenshuang Jia, Jingru Yang, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 21
Advances in Mass Spectrometry of Gangliosides Expressed in Brain Cancers
Maria Roxana Biricioiu, Mirela Sârbu, Raluca Ică, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1335-1335
Open Access | Times Cited: 4
CAR-T Therapy Beyond B-Cell Hematological Malignancies
Martina Canichella, Paolo de Fabritiis
Cells (2025) Vol. 14, Iss. 1, pp. 41-41
Open Access
B4GALNT1 Regulates Hepatocellular Carcinoma Cell Proliferation and Apoptosis via the PI3K–AKT–mTOR Pathway
Li Bie, Guangquan Chen, Xin Gen Lei, et al.
Journal of Clinical Laboratory Analysis (2025)
Open Access
GD2 is a Crucial Ganglioside in the Signal Modulation and Application as a Target of Cancer Therapeutics
Koichi Furukawa, Yuhsuke Ohmi, Kazunori Hamamura, et al.
Cancer Science (2025)
Open Access
The anti-GD2 monoclonal antibody naxitamab plus GM-CSF for relapsed or refractory high-risk neuroblastoma: a phase 2 clinical trial
Jaume Mora, Gcf Chan, Daniel A. Morgenstern, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Insights into Siglec‐7 Binding to Gangliosides: NMR Protein Assignment and the Impact of Ligand Flexibility
Cristina Di Carluccio, Luis Padilla‐Cortés, Marta Tiemblo‐Martìn, et al.
Advanced Science (2025)
Open Access
Selective requirement of glycosphingolipid synthesis for natural killer and cytotoxic T cells
Tasha Morrison, Jaelyn Vigee, Karlheinz Tovar, et al.
Cell (2025)
Closed Access
Dissecting the effect of sphingolipid metabolism gene in progression and microenvironment of osteosarcoma to develop a prognostic signature
Yujian Zhong, Yubiao Zhang, Sixing Wei, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 17
Glycan-Lectin Interactions as Novel Immunosuppression Drivers in Glioblastoma
Angelica Pace, Fabio Scirocchi, Chiara Napoletano, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6312-6312
Open Access | Times Cited: 16
Structure and function of glycosphingolipids on small extracellular vesicles
Xin He, Feng Guan, Lei Lei
Glycoconjugate Journal (2022) Vol. 39, Iss. 2, pp. 197-205
Open Access | Times Cited: 15
Gangliosides as Biomarkers of Human Brain Diseases: Trends in Discovery and Characterization by High-Performance Mass Spectrometry
Mirela Sârbu, Raluca Ică, Alina D. Zamfir
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 693-693
Open Access | Times Cited: 14
Comprehensive characterization of complex glycosphingolipids in human pancreatic cancer tissues
Karel Hořejší, Chunsheng Jin, Zuzana Vaňková, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 3, pp. 102923-102923
Open Access | Times Cited: 9
BMS-986012, an Anti–Fucosyl-GM1 Monoclonal Antibody as Monotherapy or in Combination With Nivolumab in Relapsed/Refractory SCLC: Results From a First-in-Human Phase 1/2 Study
Quincy Chu, Natasha B. Leighl, Veerle Surmont, et al.
JTO Clinical and Research Reports (2022) Vol. 3, Iss. 11, pp. 100400-100400
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top